Joseph S. Zakrzewski, Director at AN2 Therapeutics, Inc. (ANTX), bought 25,000 shares at $1.01 ($25K) on 2024-11-19, disclosed to the SEC on 2024-11-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 20,000 | $20K | 79.8% |
| 2 | $1.01 | 5,000 | $5K | 20.2% |
| Total | $1.00 avg | 25,000 | $25K | 100% |
| Filing → |
| CYT | BUY | 2022-12-08 | $28K | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |
| CYT | BUY | 2022-05-12 | $188K | — | Filing → |